Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (401-410 of 442) with videos related to

Pageof 45
Sort By:
Nature Communications|April 14, 2025
MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancerJunlong Jack Chi, Ping Xie, Mary Hongying Cheng, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2024
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort studyCarmine Valenza, Dario Trapani, Paola Zagami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion <i>BRCA</i> Mutations among Patients with Advanced Solid TumorsNeelima Vidula, Thereasa A Rich, Oliver Sartor, et al.
NPJ Breast Cancer|August 16, 2025
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2- metastatic breast cancer: a retrospective multi-institutional Consortium analysisLetizia Pontolillo, Andrew A Davis, Lorenzo Gerratana, et al.
Ebiomedicine|November 4, 2022
Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancerAndrew A Davis, Lorenzo Gerratana, Katherine Clifton, et al.
Journal of Cancer|April 19, 2018
Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10<sup>th</sup> Anniversary ConferenceWendy A Woodward, Massimo Cristofanilli, Sofia D Merajver, et al.
Journal of Cancer|May 4, 2018
International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary ConferenceNaoto T Ueno, Jose Rodrigo Espinosa Fernandez, Massimo Cristofanilli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
Circulating tumor cells dynamics after CDK4/6 inhibitor for hormone-receptor positive metastatic breast cancer: a biomarker analysis from the PACE phase II studyLorenzo Gerratana, Carolina Reduzzi, Yue Ren, et al.
Cancer Research|January 24, 2018
CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell ExpansionXuanmao Jiao, Marco A Velasco-Velázquez, Min Wang, et al.
Breast Cancer Research and Treatment|May 6, 2020
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumorsChun Wang, Zhaomei Mu, Zhong Ye, et al.
Pageof 45

Showing results (401-410 of 442) with videos related to

Sort By:
Pageof 45
Nature Communications|April 14, 2025
MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancerJunlong Jack Chi, Ping Xie, Mary Hongying Cheng, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2024
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort studyCarmine Valenza, Dario Trapani, Paola Zagami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion <i>BRCA</i> Mutations among Patients with Advanced Solid TumorsNeelima Vidula, Thereasa A Rich, Oliver Sartor, et al.
NPJ Breast Cancer|August 16, 2025
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2- metastatic breast cancer: a retrospective multi-institutional Consortium analysisLetizia Pontolillo, Andrew A Davis, Lorenzo Gerratana, et al.
Ebiomedicine|November 4, 2022
Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancerAndrew A Davis, Lorenzo Gerratana, Katherine Clifton, et al.
Journal of Cancer|April 19, 2018
Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10<sup>th</sup> Anniversary ConferenceWendy A Woodward, Massimo Cristofanilli, Sofia D Merajver, et al.
Journal of Cancer|May 4, 2018
International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary ConferenceNaoto T Ueno, Jose Rodrigo Espinosa Fernandez, Massimo Cristofanilli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
Circulating tumor cells dynamics after CDK4/6 inhibitor for hormone-receptor positive metastatic breast cancer: a biomarker analysis from the PACE phase II studyLorenzo Gerratana, Carolina Reduzzi, Yue Ren, et al.
Cancer Research|January 24, 2018
CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell ExpansionXuanmao Jiao, Marco A Velasco-Velázquez, Min Wang, et al.
Breast Cancer Research and Treatment|May 6, 2020
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumorsChun Wang, Zhaomei Mu, Zhong Ye, et al.
Pageof 45